Clik here to view.
Bracco Imaging explores using microbubbles to deliver personalized gene therapy
Bracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene...
View ArticleClik here to view.
PharmaJet touts needle-free tech for polio vaccine administration
PharmaJet touted results today from a study evaluating its needle-free injection technology as a way to administer the poliovirus vaccine. The company reported that its Tropis device was a more...
View ArticleClik here to view.
Aerie Pharmaceuticals prices $75m public offering
Aerie Pharmaceuticals (NSDQ:AERI) has priced an underwritten public offering of $75 million in shares of its common stock. The Irvine, Calif.-based company also plans to grant underwriters a 30-day...
View ArticleClik here to view.
CDC group tackles access to birth control for women in Puerto Rico
Between May 2016 and August last year, a group organized by the CDC provided services to more than 21,000 women in Puerto Rico in an attempt to boost access to contraception, lower the rate of...
View ArticleClik here to view.
Pharma revenue drives Johnson & Johnson’s Q4 beat
Shares in Johnson & Johnson (NYSE:JNJ) fell yesterday after the healthcare giant topped Wall Street’s expectations for fourth-quarter results but missed analysts’ forecast for the full-year....
View ArticleClik here to view.
FDA, FTC warn companies over deceptive opioid cessation products
The FDA and the Federal Trade Commission have posted joint warning letters to companies that make and distribute opioid cessation products. The two watchdogs warned that the companies are illegally...
View ArticleClik here to view.
Researchers develop capsule to deliver a week’s worth of HIV drugs
A team of researchers from the Massachusetts Institute of Technology and Brigham & Women’s Hospital have developed a drug-delivery capsule that can deliver a week’s worth of HIV drugs in a single...
View ArticleClik here to view.
Senate confirms former pharma exec Azar as Trump’s HHS chief
The Senate voted 55-43 today to approve president Donald Trump’s nominee for chief of the Dept. of Health and Human Services, Alex Azar. Azar is succeeding Tom Price, who was forced out after reports...
View ArticleClik here to view.
Reva implants first Fantom bioresorbable scaffold in Italy
Reva Medical (ASX:RVA) said yesterday that the first Fantom bioresorbable scaffold was implanted in Italy. The sirolimus-eluting device is made using a tyrosine-derived polymer that is visible under...
View ArticleClik here to view.
Ocular Therapeutix plans $32.5m public offering to fund NDA resubmission for...
Updated to include the offering’s pricing information. Ocular Therapeutix (NSDQ:OCUL) said today that it plans to launch an underwritten public offering of 6.5 million shares of common stock at $5.00...
View ArticleClik here to view.
How conversations with virtual people could help mitigate the opioid crisis
It often starts in the doctor’s office or the emergency room. A patient has broken their leg and will be in pain for weeks. Another patient has had back surgery and is on their way home, but it will...
View ArticleClik here to view.
Adherium to expand in U.S. market with direct-to-consumer push for smart...
Adherium Ltd. (ASK:ADR), which sells a smart inhaler technology in Europe and Australia, is reportedly looking to jump into the direct-to-consumer U.S. market in the first half of this year. The New...
View ArticleClik here to view.
Anika extends deal with UMass Amherst to develop rheumatoid arthritis therapy
Anika Therapeutics (NSDQ:ANIK) has inked a deal to extend its two-year-long collaboration with the Institute for Applied Life Sciences at the University of Massachusetts Amherst. The group plans to...
View ArticleClik here to view.
EMA committee backs label change for GSK’s Relvar Ellipta asthma therapy
GlaxoSmithKline (NYSE:GSK) and Innoviva (NSDQ:INVA) said today that a European Medicines Agency committee has backed an updated label for its once-daily asthma therapy, Relvar Ellipta. If granted...
View ArticleClik here to view.
SureFire Medical names pharma vet Szela as president, CEO | Personnel Moves –...
SureFire Medical has named pharma veteran Mary Szela as its president, CEO and board member, succeeding founder James Chomas, who has served as the company’s chief executive and president since 2009....
View ArticleClik here to view.
Report: Advocacy groups urge Congress to fund diabetes research program
Advocacy groups have reportedly warned Congress that if lawmakers don’t find permanent funding solutions for diabetes research programs, it could jeopardize important work being done around the country...
View ArticleClik here to view.
FDA wants more clinical data for Aradigm’s inhaled lung drug
Aradigm Corp. (NSDQ:ARDM) shares tumbled today after the company reported that the FDA denied its application for an inhaled drug designed to treat non-cystic fibrosis bronchiectasis patients with...
View ArticleClik here to view.
European committee backs Mylan’s insulin glargine biosimilar
Mylan (NSDQ:MYL) and Biocon announced today that a European Medicines Agency committee has recommended approval for its biosimilar insulin glargine, Semglee. The committee’s positive opinion brings the...
View ArticleClik here to view.
Boehringer Ingelheim inks outcomes-based contract with pharmacy benefit...
Boehringer Ingelheim has inked an outcomes-based contract with pharmacy benefit manager Prime Therapeutics for its oral Type II diabetes drug, Jardiance. The medication is designed to cut the risk of...
View ArticleClik here to view.
FDA to review Theravance’s application for once-daily COPD med
The FDA has accepted Theravance Biopharma‘s (NSDQ:TBPH) marketing application for revefenacin, an inhaled long-acting muscarinic antagonist designed to treat chronic obstructive pulmonary disease. The...
View Article